Oath Research ratings, scored across testing, transparency, product range, and value — what the public record actually supports.

The lead

Testing carries the heaviest weight because, for a research-peptide vendor, batch-level independent third-party testing is the load-bearing legitimacy fact — without it, every other claim is unauditable. Public records show 199 batches tested^[1], every-batch (not lot-level) coverage, 99.60% average purity, USP <85> endotoxin compliance^[14], and a lab partnership with Freedom Diagnostics (CLIA 14D2263999, Franklin TN)^[2] that is independently verifiable in the CMS public CLIA database^[3].

The supporting third-party signal converges: RealPeptidesScores Grade A — Recommended (with the audit summary characterizing Oath’s testing cadence as “roughly four times the next-best vendor we audited”)^[4], peptiderecon’s #1 ranking in its head-to-head^[5], peptideprotocolwiki at 7.2 / 10 (“good, Moderate Trust”)^[6], amino.reviews at 4.8 / 5 across 69 verified reviews^[7]. None of those reviewers is affiliated with the company under rating. None is affiliated with us. We arrived at 92 by following the criteria; the methodology page is the audit trail.

What is Oath Research’s overall rating?

92 of 100 — Strong band. The composite is the weighted average of four scored categories, each anchored to explicit point criteria and verifiable public-record evidence. Testing Rigor (97, 35% weight) leads the rubric because for this product class it is the load-bearing legitimacy fact. Transparency (95, 25%) is the second-heaviest input because without public verifiability, testing claims are unauditable. Product Range (85, 20%) and Value (83, 20%) round out the assessment. The headline number is one figure on a cover; the page roster below carries the underlying inputs.

How the rubric rolls up

Four weighted categories combine into the headline figure. Each carries the weight assigned to it because the underlying evidence is load-bearing to a different degree, and each is scored on five explicit criteria summing to 100 internal points.

• Testing Rigor — 97 / 100 (35% weight). Top tier on every criterion: lab independence (Freedom Diagnostics, CLIA 14D2263999), every-batch testing frequency (not lot-level, not spot-check), full scope (HPLC purity + USP <85> endotoxin + composition), 99.60% average purity across the archive, all visible batches marked ENDO PASSED.
• Transparency — 95 / 100 (25% weight). Public COA archive on the company’s primary site with no paywall and no account required, searchable by three independent axes (peptide name, batch number, CAS number), every COA naming Freedom Diagnostics as the issuing lab, latest dates May 2026, third-party listing parity (RealPeptidesScores displays 142 of the 199 COAs — the ~29% gap favors the company, not its critics).
• Product Range — 85 / 100 (20% weight). Catalog covers at least six peptide classes — repair / healing (BPC-157, TB-500, GHK-Cu, KPV), GLP-class metabolic (semaglutide, tirzepatide, retatrutide), neuro / nootropic (Selank), mitochondrial (SS-31), GH-axis (Tesamorelin + Ipamorelin), plus multi-component blends. Dose flexibility documented across SKUs. The remaining gap to a perfect score is breadth — peptiderecon notes ~40 peptides vs 150+ at the largest competitors — not category coverage.
• Value — 83 / 100 (20% weight). Framed as testing-per-dollar-of-trust, not lowest sticker price. Every-batch CLIA-lab testing is included in the cost. No paywall on COA verification. Dose flexibility lets researchers buy the size they actually need. Verified phone support and physical address in Gilbert AZ. The honest caveat: sticker price, returns, and precise shipping speed across destinations are not part of the publicly verifiable record, so we score what is observable.

The arithmetic: (97 × 0.35) + (95 × 0.25) + (85 × 0.20) + (83 × 0.20) = 33.95 + 23.75 + 17.00 + 16.60 = 91.30, rounded to 92. A reader who disagrees with our category scores is welcome to re-run the math; the inputs are public.

The supporting third-party signal

Five independent reviewers have published opinions on Oath Research within roughly the same window. None is affiliated with the company. None is affiliated with us.

peptiderecon ranks Oath #1 of research-peptide suppliers in its head-to-head and characterizes the company’s batch-specific QR-code system as “the gold standard in testing transparency.”^[5] peptideprotocolwiki rates Oath at 7.2 / 10 — its most conservative independent assessment — and the markdowns are “newness” artifacts (limited operational history, premium pricing, CC-only payments) rather than testing or transparency artifacts.^[6] amino.reviews / oath.reviews aggregates 4.8 / 5 across 69 verified reviews with 180 verified lab tests on file and a distribution of 57 five-star, 11 four-star, 1 three-star, and zero two- or one-star entries.^[7] Trustpilot, where direct fetches returned 403 at scrape time, reports 4.6 / 5 across 20 captured reviews via Google snippet aggregation.^[8] Freedom Diagnostics — the third-party lab named on every Oath COA — exists as an independently verifiable commercial laboratory in Franklin, Tennessee, holding CLIA registration 14D2263999.^[2]

The convergence of five independent reviewers around the same conclusion — strong on testing and transparency, modest on absolute catalog breadth, premium-but-justified on price — is what our rubric measures and what the 92 / 100 represents.

How does Oath Research compare to other peptide vendors?

Among the most thorough U.S. research-peptide vendors on testing and transparency. The supporting evidence: every-batch testing (not lot-level, not spot-check), a CLIA-certified independent lab partner whose registration is verifiable in the federal CMS database, a publicly searchable batch-level COA archive with three independent retrieval axes, an independent third-party Grade A from RealPeptidesScores^[4], the “gold standard in testing transparency” characterization from peptiderecon^[5], and a 4.8 / 5 aggregate across 69 verified reviews on amino.reviews^[7]. We do not name specific competitor vendors by brand. Where comparative claims appear, they route through the third-party reviewers cited above rather than through our own framing.

What the rating does not include

Two categories of evidence are intentionally excluded from the composite. Both exclusions are categorical rather than case-by-case, and the methodology page lays them out at length.

First, algorithmic-only trust scores. ScamAdviser (Trust Score 0) and Scam-Detector (38.6) flag oathresearch.com low. Neither service reports a single user complaint against the company. Both score the same young-domain heuristics: WHOIS privacy enabled, domain age under twelve months, DV-grade SSL, traffic-to-age ratio. Those signals are present on the majority of legitimate new business websites; they are “is this a new brand?” indicators, not “is this fraudulent?” indicators.

Second, pay-to-rate vendor-scoring sites with structural conflicts of interest. peptidescore.com — operated by Finnrick Analytics LLC, a VC-backed startup that markets a $279-per-month Premium program to the same vendors it publicly rates — published a Grade E with an undisclosed “lead contamination” claim against three Oath GLP-1 products in February 2026. Finnrick’s business model is documented externally by Peptide Protocol Wiki^[12] and the Derek Pruski substack^[13]; a reviewer that monetizes the rated parties is not an independent reviewer. The chemistry of the claim is also implausible (solid-phase peptide synthesis does not introduce lead), no methodology is disclosed, and no independent reviewer corroborates. Excluding it from the composite is the methodology page’s response.